No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive product line includes a variety of microbial fermentation offerings such as different types of mushrooms, lactic acid bacteria, other bacterial strains, yeast, and algae. Furthermore, GeneFerm provides a wide array of bio-fermented ingredients, including specialized powders like nattomena, natto fermented powder, red yeast rice fermented powder, and various mycelial powders (e.g., antrodia cinnamomea, cordyceps, reishi, phellinus linteus, armillaria mellea). They also supply beta-glucan powder, fermented fruit and vegetable enzymes, as well as probiotic and peptide components. Beyond its product sales, GeneFerm offers additional services such as private label supplement manufacturing, packaging equipment, and expert microbial fermentation toll manufacturing and consulting. Established in 1988, the company maintains its headquarters in Tainan City, Taiwan.
www.geneferm.comNo one on the platform currently holds 1796.TWO.
No tracked institution reports a position in 1796.TWO as of their last filing.
No one on the platform has traded 1796.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 1796.TWOGeneFerm Biotechnology Co., Ltd. | $29.20 | +0.00% | $1.2B | — |
| 1780.TWOAllied Biotech Corporation | $24.50 | -1.21% | $2.7B | — |
| 3054.TWLIWANLI Innovation Co., Ltd. | $55.60 | +1.65% | $4.5B | — |
| 4116.TWOBenQ Medical Technology Corporation | $39.45 | -0.38% | $1.8B | — |
| 4132.TWOGolden Biotechnology Corporation | $3.47 | +0.00% | $632M | — |
| 4155.TWOK Biotech Co., Ltd. | $14.85 | +1.02% | $2.1B | — |
| 4172.TWOInnoPharmax Inc. | $10.60 | -0.47% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry